Business Description
Harbin Gloria Pharmaceuticals Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100000QG8
Share Class Description:
SZSE:002437: Class ACompare
Compare
Traded in other countries / regions
002437.China IPO Date
2010-06-23Description
Harbin Gloria Pharmaceuticals Co Ltd is a tech biopharmaceutical enterprise. It is engaged in the research, development, production, and sale of pharmaceutical products primarily in China. The company offers cardiovascular drugs; cardiac cerebrovascular medication; vitamins and minerals; urinary tract drugs; urinary system medication; anti-tumor medication; endocrine system drugs; anti-infective drugs; digestive system medication; respiratory medication; and other medications.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.65 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.24 | |||||
Debt-to-EBITDA | 1.73 | |||||
Interest Coverage | 7.76 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.83 | |||||
Beneish M-Score | -2.93 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -4.9 | |||||
3-Year EBITDA Growth Rate | -26.2 | |||||
3-Year Book Growth Rate | -3.5 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 73.63 | |||||
9-Day RSI | 64.56 | |||||
14-Day RSI | 57.37 | |||||
6-1 Month Momentum % | -21.22 | |||||
12-1 Month Momentum % | -9.39 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.94 | |||||
Quick Ratio | 0.78 | |||||
Cash Ratio | 0.6 | |||||
Days Inventory | 68.1 | |||||
Days Sales Outstanding | 27.91 | |||||
Days Payable | 25.19 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 17.35 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 57.48 | |||||
Operating Margin % | 10.14 | |||||
Net Margin % | 6.01 | |||||
FCF Margin % | 12.38 | |||||
ROE % | 8.9 | |||||
ROA % | 4.39 | |||||
ROIC % | 6.59 | |||||
ROC (Joel Greenblatt) % | 22.86 | |||||
ROCE % | 13.61 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 27.57 | |||||
PE Ratio without NRI | 24.43 | |||||
Shiller PE Ratio | 383.02 | |||||
Price-to-Owner-Earnings | 35.74 | |||||
PS Ratio | 1.68 | |||||
PB Ratio | 2.42 | |||||
Price-to-Tangible-Book | 3.52 | |||||
Price-to-Free-Cash-Flow | 13.5 | |||||
Price-to-Operating-Cash-Flow | 12.14 | |||||
EV-to-EBIT | 16.67 | |||||
EV-to-EBITDA | 16.67 | |||||
EV-to-Revenue | 1.62 | |||||
EV-to-FCF | 13.07 | |||||
Price-to-Projected-FCF | 0.83 | |||||
Price-to-Median-PS-Value | 0.83 | |||||
Price-to-Graham-Number | 1.95 | |||||
Earnings Yield (Greenblatt) % | 6 | |||||
FCF Yield % | 7.17 | |||||
Forward Rate of Return (Yacktman) % | 2.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Harbin Gloria Pharmaceuticals Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 2,538.003 | ||
EPS (TTM) (Â¥) | 0.07 | ||
Beta | 0.89 | ||
Volatility % | 43.01 | ||
14-Day RSI | 57.37 | ||
14-Day ATR (Â¥) | 0.06968 | ||
20-Day SMA (Â¥) | 1.798 | ||
12-1 Month Momentum % | -9.39 | ||
52-Week Range (Â¥) | 1.66 - 3.15 | ||
Shares Outstanding (Mil) | 2,270.51 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Harbin Gloria Pharmaceuticals Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Harbin Gloria Pharmaceuticals Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Harbin Gloria Pharmaceuticals Co Ltd Frequently Asked Questions
What is Harbin Gloria Pharmaceuticals Co Ltd(SZSE:002437)'s stock price today?
The current price of SZSE:002437 is ¥1.93. The 52 week high of SZSE:002437 is ¥3.15 and 52 week low is ¥1.66.
When is next earnings date of Harbin Gloria Pharmaceuticals Co Ltd(SZSE:002437)?
The next earnings date of Harbin Gloria Pharmaceuticals Co Ltd(SZSE:002437) is .
Does Harbin Gloria Pharmaceuticals Co Ltd(SZSE:002437) pay dividends? If so, how much?
Harbin Gloria Pharmaceuticals Co Ltd(SZSE:002437) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |